188 related articles for article (PubMed ID: 33551105)
1. Genotoxicity of selected pyrrolizidine alkaloids in human hepatoma cell lines HepG2 and Huh6.
Hadi NSA; Bankoglu EE; Schott L; Leopoldsberger E; Ramge V; Kelber O; Sievers H; Stopper H
Mutat Res Genet Toxicol Environ Mutagen; 2021; 861-862():503305. PubMed ID: 33551105
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of pyrrolizidine alkaloids in metabolically inactive human cervical cancer HeLa cells co-cultured with human hepatoma HepG2 cells.
Hadi NSA; Bankoglu EE; Stopper H
Arch Toxicol; 2023 Jan; 97(1):295-306. PubMed ID: 36273350
[TBL] [Abstract][Full Text] [Related]
3. Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cells.
Rutz L; Gao L; Küpper JH; Schrenk D
Arch Toxicol; 2020 Dec; 94(12):4159-4172. PubMed ID: 32910235
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Pattern of Hepatotoxic Pyrrolizidine Alkaloids in Liver Cells.
Geburek I; Rutz L; Gao L; Küpper JH; These A; Schrenk D
Chem Res Toxicol; 2021 Apr; 34(4):1101-1113. PubMed ID: 33719395
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells.
Abdelfatah S; Naß J; Knorz C; Klauck SM; Küpper JH; Efferth T
Cell Biol Toxicol; 2022 Apr; 38(2):325-345. PubMed ID: 33884520
[TBL] [Abstract][Full Text] [Related]
6. Potency ranking of pyrrolizidine alkaloids in metabolically competent human liver cancer cells and primary human hepatocytes using a genotoxicity test battery.
Haas M; Wirachowski K; Thibol L; Küpper JH; Schrenk D; Fahrer J
Arch Toxicol; 2023 May; 97(5):1413-1428. PubMed ID: 36928417
[TBL] [Abstract][Full Text] [Related]
7. Relative potency of fifteen pyrrolizidine alkaloids to induce DNA damage as measured by micronucleus induction in HepaRG human liver cells.
Allemang A; Mahony C; Lester C; Pfuhler S
Food Chem Toxicol; 2018 Nov; 121():72-81. PubMed ID: 30125636
[TBL] [Abstract][Full Text] [Related]
8. The chemical structure impairs the intensity of genotoxic effects promoted by 1,2-unsaturated pyrrolizidine alkaloids in vitro.
Buchmueller J; Enge AM; Peters A; Ebmeyer J; Küpper JH; Schäfer B; Braeuning A; Hessel-Pras S
Food Chem Toxicol; 2022 Jun; 164():113049. PubMed ID: 35500694
[TBL] [Abstract][Full Text] [Related]
9. OCT1-dependent uptake of structurally diverse pyrrolizidine alkaloids in human liver cells is crucial for their genotoxic and cytotoxic effects.
Haas M; Ackermann G; Küpper JH; Glatt H; Schrenk D; Fahrer J
Arch Toxicol; 2023 Dec; 97(12):3259-3271. PubMed ID: 37676300
[TBL] [Abstract][Full Text] [Related]
10. The in vitro genotoxicity potency of mixtures of pyrrolizidine alkaloids can be explained by dose addition of the individual mixture components.
Allemang A; Mahony C; Pfuhler S
Environ Mol Mutagen; 2022 Dec; 63(8-9):400-407. PubMed ID: 36258291
[TBL] [Abstract][Full Text] [Related]
11. Prediction of in vivo genotoxicity of lasiocarpine and riddelliine in rat liver using a combined in vitro-physiologically based kinetic modelling-facilitated reverse dosimetry approach.
Chen L; Peijnenburg A; de Haan L; Rietjens IMCM
Arch Toxicol; 2019 Aug; 93(8):2385-2395. PubMed ID: 31289892
[TBL] [Abstract][Full Text] [Related]
12. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure-activity relationships.
Hincks JR; Kim HY; Segall HJ; Molyneux RJ; Stermitz FR; Coulombe RA
Toxicol Appl Pharmacol; 1991 Oct; 111(1):90-8. PubMed ID: 1949039
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pyrrolizidine alkaloid-induced genotoxicity using metabolically competent TK6 cell lines.
Li X; He X; Chen S; Guo X; Bryant MS; Guo L; Manjanatha MG; Zhou T; Witt KL; Mei N
Food Chem Toxicol; 2020 Nov; 145():111662. PubMed ID: 32798647
[TBL] [Abstract][Full Text] [Related]
14. Assessment of pyrrolizidine alkaloid-induced toxicity in an in vitro screening model.
Li YH; Kan WL; Li N; Lin G
J Ethnopharmacol; 2013 Nov; 150(2):560-7. PubMed ID: 24045176
[TBL] [Abstract][Full Text] [Related]
15. Determination of genotoxic potencies of pyrrolizidine alkaloids in HepaRG cells using the γH2AX assay.
Louisse J; Rijkers D; Stoopen G; Holleboom WJ; Delagrange M; Molthof E; Mulder PPJ; Hoogenboom RLAP; Audebert M; Peijnenburg AACM
Food Chem Toxicol; 2019 Sep; 131():110532. PubMed ID: 31154085
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of apoptosis and autophagy by pyrrolizidine alkaloid clivorine in human hepatoma Huh-7.5 cells and its toxic implication.
Liu W; Li X; Zhou B; Fang S; Ho W; Chen H; Liang H; Ye L; Tang J
PLoS One; 2017; 12(6):e0179379. PubMed ID: 28650983
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity screening and ranking of structurally different pyrrolizidine alkaloids in zebrafish.
Pan Y; Ma J; Zhao H; Fu PP; Lin G
Food Chem Toxicol; 2023 Aug; 178():113903. PubMed ID: 37390955
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity of Pyrrolizidine Alkaloid Compound Intermedine: Comparison with Other Pyrrolizidine Alkaloids and Its Toxicological Mechanism.
Wang Z; Han H; Wang C; Zheng Q; Chen H; Zhang X; Hou R
Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941687
[TBL] [Abstract][Full Text] [Related]
19. Use of HepG2 cell line for direct or indirect mutagens screening: comparative investigation between comet and micronucleus assays.
Valentin-Severin I; Le Hegarat L; Lhuguenot JC; Le Bon AM; Chagnon MC
Mutat Res; 2003 Apr; 536(1-2):79-90. PubMed ID: 12694748
[TBL] [Abstract][Full Text] [Related]
20. Development of an in vitro screening method of acute cytotoxicity of the pyrrolizidine alkaloid lasiocarpine in human and rodent hepatic cell lines by increasing susceptibility.
Forsch K; Schöning V; Disch L; Siewert B; Unger M; Drewe J
J Ethnopharmacol; 2018 May; 217():134-139. PubMed ID: 29454024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
